Oct 24, 2008 | Laboratory Management and Operations, Laboratory Pathology
Use of antibodies that detect biomarkers in as little as 15 minutes now allows researchers at the University of Leeds in the United Kingdom to identify such diseases as prostate and ovarian cancer, stroke, multiple sclerosis (MS), heart disease, and fungal infections. Using biosensors to identify the molecular markers for disease, the technology is much faster than current testing methods. One goal of this research is to provide a way for hospitals to use this technology for rapid diagnosis....
